Tega Therapeutics Inc.
San Diego, CA
- UEI
- C1LJLCS3PM51
- CAGE
- 6W1N1
- Primary NAICS
- 622110 General Medical and Surgical Hospitals
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3550 General Atomics Ct Ste G02-102, San Diego, CA 92121, USA
- Website
- tegatherapeutics.com
- Founded
- 2014
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Not on record | W911NF1730003 | $3,040,031 | |
| Bioindustrial Manufacturing And Design Ecosystem | FA86502125028 | $2,058,498 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Zabbio, Inc. | Del Mar, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Epigen Biosciences Inc. | San Diego, CA | 325199 All Other Basic Organic Chemical Manufacturing |
| Proteogenomics Research Institute For Systems Medicine | San Diego, CA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Research And Development | San Diego, CA | — |
| Genetobe Inc. | Ann Arbor, MI | — |
About the company
Tega Therapeutics Inc. is a pharmaceutical research and development company based in San Diego, California, specializing in developing innovative biotechnology solutions for rare diseases and complex medical conditions. Registered in the System for Award Management (SAM) since 2013, the company focuses on engineering advanced therapeutic approaches, particularly in the areas of enzyme replacement therapy and recombinant biological production. The company operates as a for-profit corporate entity and has been actively pursuing federal grant funding to advance its research into novel medical treatments.
Through its federal grant awards, Tega Therapeutics Inc. has secured multiple project grants from prestigious federal agencies including the National Institute of Neurological Disorders and Stroke (NINDS), National Heart Lung and Blood Institute, and the National Science Foundation. The company's grant-funded research has concentrated on developing treatments for rare neurological conditions such as GM1 gangliosidosis, a lysosomal storage disease, and exploring innovative approaches to heparin production using recombinant cell line technologies. Specific project objectives have included engineering mammalian cell lines to produce recombinant enzymes, developing non-anticoagulant heparin for treating chronic obstructive pulmonary disease, and creating alternative production methods for essential medical compounds that currently rely on animal-sourced materials. The company has also received a sub-grant award from the Bioindustrial Manufacturing And Design Ecosystem, indicating its involvement in broader biotechnological innovation networks. These grants, ranging from approximately $461,701 to $500,000, demonstrate Tega Therapeutics' commitment to advancing medical research through federally supported scientific innovation.
Quick answers
Is Tega Therapeutics Inc. registered in SAM.gov?
Yes. Tega Therapeutics Inc.'s SAM.gov registration is active through September 5, 2027.
What is Tega Therapeutics Inc.'s CAGE code?
Tega Therapeutics Inc.'s CAGE code is 6W1N1, and its Unique Entity ID (UEI) is C1LJLCS3PM51.
What is Tega Therapeutics Inc.'s most recent federal award?
Tega Therapeutics Inc.'s most recent federal grant award is Title: new clinical biomarkers for GM1 gamgliosidosis (R43NS139721), from National Institute of Neurological Disorders and Stroke (NIH), on August 5, 2025.
On GovTribe
See Tega Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors